These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 30010069

  • 1. Denosumab Treatment for a Residual Giant Cell Tumor of the Clivus: A Case Report and Review of the Literature.
    Huh A, Villelli N, Martinez D, Ting J, Birhiray R, Payner TD, Kulwin CG.
    World Neurosurg; 2018 Oct; 118():98-101. PubMed ID: 30010069
    [Abstract] [Full Text] [Related]

  • 2. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature.
    Inoue A, Ohnishi T, Kohno S, Nishikawa M, Nishida N, Ohue S.
    World Neurosurg; 2016 Jul; 91():674.e1-6. PubMed ID: 27113403
    [Abstract] [Full Text] [Related]

  • 3. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
    Goto Y, Furuno Y, Kawabe T, Ohwada K, Tatsuzawa K, Sasajima H, Hashimoto N.
    J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173
    [Abstract] [Full Text] [Related]

  • 4. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
    Bardakhchyan S, Kager L, Danielyan S, Avagyan A, Karamyan N, Vardevanyan H, Mkhitaryan S, Papyan R, Zohrabyan D, Safaryan L, Sargsyan L, Harutyunyan L, Hakobyan L, Iskanyan S, Tamamyan G.
    Ital J Pediatr; 2017 Mar 29; 43(1):32. PubMed ID: 28356124
    [Abstract] [Full Text] [Related]

  • 5. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE.
    Spine J; 2024 Jun 29; 24(6):1056-1064. PubMed ID: 38301904
    [Abstract] [Full Text] [Related]

  • 6. Unresectable Clival Giant Cell Tumor, Tumor Control With Denosumab After Relapse: A Case Report and Systematic Review of the Literature.
    Pionelli MG, Asaftei SD, Tirtei E, Campello A, Di Rosa G, Fagioli F.
    J Pediatr Hematol Oncol; 2022 Jul 01; 44(5):201-209. PubMed ID: 35537059
    [Abstract] [Full Text] [Related]

  • 7. Endoscopic endonasal treatment of a large clival giant cell tumor invading the cavernous sinus and temporal lobe.
    Yildirim AE, Divanlioglu D, Cetinalp NE, Ozhamam E, Belen AD.
    J Craniofac Surg; 2014 Mar 01; 25(2):446-8. PubMed ID: 24481168
    [Abstract] [Full Text] [Related]

  • 8. Treatment of Clival Giant Cell Tumor: A Case Report and Literature Review.
    Yang JY, Kang H, Kim YH.
    Brain Tumor Res Treat; 2024 Apr 01; 12(2):132-140. PubMed ID: 38742263
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V.
    Am J Surg Pathol; 2016 Jan 01; 40(1):72-80. PubMed ID: 26414220
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration.
    Freeman JL, Oushy S, Schowinsky J, Sillau S, Youssef AS.
    World Neurosurg; 2016 Dec 01; 96():47-57. PubMed ID: 27269210
    [Abstract] [Full Text] [Related]

  • 14. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R.
    World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843
    [Abstract] [Full Text] [Related]

  • 15. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E.
    Spine J; 2014 Jul 01; 14(7):e15-21. PubMed ID: 24534393
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
    Rekhi B, Verma V, Gulia A, Jambhekar NA, Desai S, Juvekar SL, Bajpai J, Puri A.
    Pathol Oncol Res; 2017 Jan 01; 23(1):157-164. PubMed ID: 27722984
    [Abstract] [Full Text] [Related]

  • 17. A single-center experience with giant cell tumors of sphenoid bone and clivus.
    Yaprak Bayrak B, Özcan E, Vural Ç, Emengen A, Çabuk B, Ceylan S.
    Tumori; 2021 Dec 01; 107(6):NP94-NP100. PubMed ID: 34374310
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Denosumab salvage therapy in an 11-year-old boy with locally recurrent unresectable giant cell tumor of the lumbar spine after surgery.
    Luo Y, Xiu P, Chen H, Zeng J, Song Y, Li T.
    Neurochirurgie; 2023 May 01; 69(3):101427. PubMed ID: 36828057
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.